Literature DB >> 11230456

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study.

R R Reinert1, S Simic, A Al-Lahham, S Reinert, M Lemperle, R Lütticken.   

Abstract

Clinically significant pneumococcal isolates were prospectively collected from outpatients with respiratory tract infections by 19 different clinical microbiology laboratories in Germany. Resistance rates in a total of 961 isolates were as follows: penicillin, 6.6%; clarithromycin, 10.6%; tetracycline, 13.9%; and levofloxacin, 0.1%. Among 324 isolates from children, pneumococcal serotypes 19F (17.0%), 23F (13.0%), and 6B (11.7%) were the predominant types.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11230456      PMCID： PMC87902          DOI： 10.1128/JCM.39.3.1187-1189.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?

Authors:  F Baquero
Journal:  J Chemother       Date:  1999-02       Impact factor: 1.714

2.  Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary.

Authors:  A Marton; M Gulyas; R Munoz; A Tomasz
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

3.  Identification of the tetracycline resistance gene, tet(O), in Streptococcus pneumoniae.

Authors:  C A Widdowson; K P Klugman; D Hanslo
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

4.  Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study.

Authors:  A J Clavo-Sánchez; J A Girón-González; D López-Prieto; J Canueto-Quintero; A Sánchez-Porto; A Vergara-Campos; P Marín-Casanova; J A Córdoba-Doña
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

5.  Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy.

Authors:  A Marchese; E Tonoli; E A Debbia; G C Schito
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

6.  Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992-1994.

Authors:  R R Reinert; A Queck; A Kaufhold; M Kresken; R Lütticken
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

7.  Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.

Authors:  P Descheemaeker; S Chapelle; C Lammens; M Hauchecorne; M Wijdooghe; P Vandamme; M Ieven; H Goossens
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

8.  Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

Authors:  R von Kries; A Siedler; H J Schmitt; R R Reinert
Journal:  Clin Infect Dis       Date:  2000-08-30       Impact factor: 9.079

9.  Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.

Authors:  A Tait-Kamradt; T Davies; M Cronan; M R Jacobs; P C Appelbaum; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

10.  Characterization of conjugative transposon Tn5251 of Streptococcus pneumoniae.

Authors:  R Provvedi; R Manganelli; G Pozzi
Journal:  FEMS Microbiol Lett       Date:  1996-01-15       Impact factor: 2.742
View more
  17 in total

1.  Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae.

Authors:  Maria P Montanari; Ileana Cochetti; Marina Mingoia; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 2.  Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany.

Authors:  M van der Linden; R R Reinert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-30       Impact factor: 3.267

3.  Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.

Authors:  Ralf René Reinert; Mark van der Linden; Adnan Al-Lahham
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones.

Authors:  Ralf René Reinert; Michael R Jacobs; Peter C Appelbaum; Saralee Bajaksouzian; Soraia Cordeiro; Mark van der Linden; Adnan Al-Lahham
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 5.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe.

Authors:  Ralf René Reinert; Adrian Ringelstein; Mark van der Linden; Murat Yücel Cil; Adnan Al-Lahham; Franz-Josef Schmitz
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites.

Authors:  Maria Rosario Amezaga; Philip E Carter; Phillip Cash; Hamish McKenzie
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.

Authors:  Michael Kresken; Beate Henrichfreise; Simone Bagel; Johannes Brauers; Bernd Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

9.  Efficacy and tolerability of moxifloxacin in 2338 patients with acute exacerbation of chronic bronchitis.

Authors:  J Barth; H Landen
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 10.  Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective.

Authors:  Stephan Harbarth; Werner Albrich; Christian Brun-Buisson
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.